Stein Steven H 4
4 · INCYTE CORP · Filed Nov 7, 2025
Insider Transaction Report
Form 4
INCYTE CORPINCY
Stein Steven H
EVP & Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-11-05$83.83/sh+1,194$100,093→ 104,080 total - Exercise/Conversion
Common Stock
2025-11-05$95.76/sh+1,044$99,973→ 108,119 total - Exercise/Conversion
Common Stock
2025-11-05$95.76/sh+2,995$286,801→ 107,075 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-11-05−1,194→ 0 totalExercise: $83.83Exp: 2026-07-14→ Common Stock (1,194 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-11-05−2,995→ 0 totalExercise: $95.76Exp: 2026-01-06→ Common Stock (2,995 underlying) - Sale
Common Stock
2025-11-05$102.20/sh−5,233$534,813→ 102,886 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2025-11-05−1,044→ 0 totalExercise: $95.76Exp: 2026-01-06→ Common Stock (1,044 underlying)
Footnotes (3)
- [F1]This includes an aggregate of 100,327 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
- [F2]Beginning July 15, 2016, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- [F3]Beginning January 7, 2016, options become exercisable in full on January 7, 2020.